Ms Hyland has a strong track record within the biopharma sector, bringing with her over 25 years of financial experience with both public and private companies. Most recently, she served as Chief Financial Officer of BBI Diagnostics Group Ltd and FTSE-listed Vectura Group plc (LSE: VEC).
Ms Hyland currently serves as Non-executive Director and Chair of the Audit Committee of the global pharmaceutical and services company, Clinigen Group plc (AIM:CLIN). Prior to Vectura, she held a number of senior finance position, including Director of Corporate Finance at the then FTSE 100 Celltech Group plc, Medeva plc and KPMG.
Ms Hyland is a Chartered Accountant (FCA), a Corporate Tax Adviser (CTA–AITI) and holds a degree in business studies from Trinity College, Dublin.